HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
HIV infection results in elevated beta-amyloid (Aβ) levels in the brain, but the underlying mechanisms are unclear. Here, the authors show that amyloid precursor protein inhibits virion production and that HIV Gag, counteracting this antiviral function, results in secretase-dependent Aβ production a...
Guardado en:
Autores principales: | Qingqing Chai, Vladimir Jovasevic, Viacheslav Malikov, Yosef Sabo, Scott Morham, Derek Walsh, Mojgan H. Naghavi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bb6852761304008b18756776bcceede |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration
por: Qingqing Chai, et al.
Publicado: (2018) -
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Marlies Gijs, et al.
Publicado: (2021) -
Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.
por: Nina Stemmer, et al.
Publicado: (2013) -
Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Li Zhao, et al.
Publicado: (2021) -
Cytotoxic aggregation and amyloid formation by the myostatin precursor protein.
por: Carlene S Starck, et al.
Publicado: (2010)